Ramurthy S, Lee M S, Nakanishi H, Shen R, Kahn M
Department of Pathobiology, University of Washington, Seattle 98195.
Bioorg Med Chem. 1994 Sep;2(9):1007-13. doi: 10.1016/s0968-0896(00)82049-0.
Attempts to enhance the efficacy of our previously reported CD4 CDR2-like (residues 40-45) mimetic 1 by incorporation of the critical guanidine residue Arg-59 of CD4 are described.
本文描述了通过引入CD4关键的胍基残基Arg-59来提高我们之前报道的CD4 CDR2样(40-45位残基)模拟物1的功效的尝试。